MPS Bioceutical Corp.

Ordinary Shares International Reporting
Verified Company Profile 10/20/2017
Contact Info
  • Yonge Norton Centre
  • 5255 Yonge Street, Suite 701
  • Toronto, ONT M2N 6P4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Quarterly Report
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: Canada
Year of Inc. 1974
Employees 90 a/o May 04, 2017
Company Officers/Contacts
W. Scott Boyes CEO
Elizabeth M. Stavola COO
Randall G. Stafford CFO
Jeremy S. Budd General Counsel, Corporate Secretary, Vice President
Company Directors
W. Scott Boyes Chairman
Andrew R. Ryan
Richard S. Segerblom
Randall G. Stafford
Elizabeth M. Stavola
Miles D. Thompson
Company Notes
  • Formerly=Canadian Bioceutical Corp until 11-2017
  • Formerly=Allegiance Equity Corp until 12-2014
Service Providers
Accounting/Auditing Firm
Deloitte LLP
22 Adelaide Street West
Suite 200
Bay Adelaide Center, East Tower
Toronto, ONT, M5H 0A9

Legal Counsel
PO Box 70043
Rimrock Plaza PO
Toronto, ONT, M5V 3B6

Investor Relations Firm
National Equicom
320 Front Street West
Suite 1600
Toronto, ONT, M5V 3B6

MPXEF Security Details
Share Structure
Market Value1 $133,134,516 a/o Nov 17, 2017
Authorized Shares Unlimited a/o Oct 19, 2017
Outstanding Shares 259,521,473 a/o Oct 19, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 250,455,973 a/o Oct 19, 2017
Par Value Not Available
Transfer Agent(s)
Shareholders of Record 114 a/o Oct 19, 2017
Non US Stock Exchange Listing
MPX - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 11,206 (-90.89%)
Oct 13, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security